NEW YORK, NY / ACCESS Newswire / May 11, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=147960&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds Geron Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN

Green Dot Corporation (GDOT) Q1 2025 Earnings Call Transcript — Neutral

GDOT   Seeking Alpha — May 11, 2025

Green Dot Corporation (NYSE:GDOT ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Tim Willi - Senior Vice President, Finance and Corporate Development Bill Jacobs - Chairman of the Board and Interim Chief Executive Officer Jess Unruh - Chief Financial Officer Chris Ruppel - Chief Revenue Officer Conference Call Participants Tim Switzer - KBW Ramsey El-Assal - Barclays Cristopher Kennedy - William Blair Operator Good day, and welcome to the Green Dot Corp. First Quarter 2025 Conference Call. [Operator Instructions] Please note, this event is being recorded.

image for news Green Dot Corporation (GDOT) Q1 2025 Earnings Call Transcript

2 Affordable Dividend Growth Stocks to Buy And Hold Forever — Positive

DG  PINE   The Motley Fool — May 11, 2025

Long-term investing is the key to sustainable returns in the stock market because it smooths out near-term volatility to let a company's fundamental value shine through. Regular dividend payments sweeten the deal by providing consistent income that can grow larger over time.

image for news 2 Affordable Dividend Growth Stocks to Buy And Hold Forever

Matrix Service Company (MTRX) Q3 2025 Earnings Call Transcript — Neutral

MTRX   Seeking Alpha — May 11, 2025

Matrix Service Company (NASDAQ:MTRX ) Q3 2025 Earnings Conference Call May 8, 2025 10:30 AM ET Company Participants Kellie Smythe - Senior Director of Investor Relations John Hewitt - President and Chief Executive Officer Kevin Cavanah - Vice President, Chief Financial Officer Conference Call Participants John Franzreb - Sidoti & Company Brent Thielman - D.A. Davidson Operator Good morning, and welcome to the Matrix Service Company conference call to discuss results for the third quarter of fiscal 2025.

image for news Matrix Service Company (MTRX) Q3 2025 Earnings Call Transcript

Warren Buffett surprised Berkshire Hathaway (BRK.A 0.18%) (BRK.B 0.09%) shareholders earlier this month at the annual shareholders meeting when he announced that he would be ending a 60-year reign as the company's president and CEO at the end of 2025. Greg Abel will take over both roles, and Buffett will move to the position of chairman.

image for news In His Final Annual Meeting as Berkshire Hathaway's CEO, Warren Buffett Once Again Repudiated President Donald Trump's Tariffs

OpenAI is reportedly in the middle of reworking its multibillion-dollar agreement with Microsoft. The negotiated deal would allow the artificial intelligence (AI) company to someday launch an initial public offering (IPO), while protecting Microsoft's access to AI models, the Financial Times (FT) reported Sunday (May 11).

image for news OpenAI and Microsoft Reportedly Rework Pact Ahead of Possible IPO

The Best Stocks to Invest $1,000 in Right Now — Neutral

AMZN  NVDA  TGT   The Motley Fool — May 11, 2025

The stock market may not seem like the friendliest place for investors right now, with the three major benchmarks -- the S&P 500, the Dow Jones Industrial Average, and the Nasdaq Composite -- down since the start of the year. Worries about President Donald Trump's plan to impose tariffs on imports have halted the positive momentum that carried indexes over the past two years.

image for news The Best Stocks to Invest $1,000 in Right Now

Banco Santander-Chile (BSAC) Q1 2025 Earnings Call Transcript — Neutral

BSAC   Seeking Alpha — May 11, 2025

Banco Santander-Chile (NYSE:BSAC ) Q1 2025 Earnings Conference Call May 8, 2025 10:00 AM ET Company Participants Cristian Vicuna - Chief of Strategic Planning and Investor Relations Patricia Perez - Interim Chief Financial Officer Andres Sansone - Chief Economist Conference Call Participants Ernesto Gabilondo - Bank of America Merrill Lynch Beatriz Abreu - Goldman Sachs Neha Agarwala - HSBC Daniel Mora - Credicorp Capital Marlon Medina Robles - JPMorgan Ewald Stark - BICE Inversiones Operator Ladies and gentlemen, thank you for standing by. I would like to welcome you to Banco Santander-Chile First Quarter 2025 Earnings Conference Call on the …

image for news Banco Santander-Chile (BSAC) Q1 2025 Earnings Call Transcript

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.

image for news Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Artificial intelligence (AI) is a powerful tool, and it's likely to change the world in interesting, if not incredible, ways. But AI doesn't exist in a vacuum.

image for news AI Data Center Demand Is Growing Too Fast. That's an Opportunity for Bloom Energy.

The keys to a richer retirement come down to three factors: how much you invest, how long you invest that money, and the return you earn on your investment . The more of each input you have, the richer you'll become in retirement.

image for news Want to Retire Richer? This Top ETF's Brilliant Strategy Could Turn $250 a Month Into $1 Million in 31 Years.

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and waist circumference reduction INDIANAPOLIS , May 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound (tirzepatide), a dual GIP and GLP-1 receptor agonist, compared to Wegovy (semaglutide), a mono GLP-1 receptor agonist, in adults living with obesity, or overweight with at least one weight-related medical problem and without diabetes.

image for news Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

NEW YORK, NY / ACCESS Newswire / May 11, 2025 / If you suffered a loss on your TFI International Inc. (NYSE:TFII) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tfi-international-inc-lawsuit-submission-form?prid=147959&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds TFI International Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2025 - TFII

NEW YORK, NY / ACCESS Newswire / May 11, 2025 / If you suffered a loss on your Fluence Energy, Inc. (NASDAQ:FLNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluence-energy-lawsuit-submission-form?prid=147958&wire=1 or contact Joseph E. Levi, Esq.

image for news Investors who lost money on Fluence Energy, Inc.(FLNC) should contact Levi & Korsinsky about pending Class Action - FLNC

nLIGHT, Inc. (LASR) Q1 2025 Earnings Call Transcript — Neutral

LASR   Seeking Alpha — May 11, 2025

nLIGHT, Inc. (NASDAQ:LASR ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants John Marchetti - Vice President of Corporate Development & Head of Investor Relations Scott Keeney - Chairman & Chief Executive Officer Joe Corso - Chief Financial Officer Conference Call Participants Jim Ricchiuti - Needham & Company Greg Palm - Craig-Hallum Capital Group Ruben Roy - Stifel Troy Jensen - Cantor Fitzgerald Mark Miller - The Benchmark Company Operator Good evening ladies and gentlemen and welcome to the nLIGHT Incorporation First Quarter 2025 Earnings Conference Call. At this time, all lines are in listen-only …

image for news nLIGHT, Inc. (LASR) Q1 2025 Earnings Call Transcript

BBB Foods Inc. (TBBB) Q1 2025 Earnings Call Transcript — Neutral

TBBB   Seeking Alpha — May 11, 2025

BBB Foods Inc. (NYSE:TBBB ) Q1 2025 Earnings Conference Call May 8, 2025 12:00 PM ET Company Participants Anthony Hatoum - Chairman & Chief Executive Officer Eduardo Pizzuto - Chief Financial Officer Conference Call Participants Bob Ford - Merrill Lynch Alvaro Garcia - BTG Pactual Joseph Giordano - JPMorgan Alejandro Fuchs - Itaú Ulises Argote - Santander Andrew Ruben - Morgan Stanley Héctor Maya - Scotiabank Operator Good morning, everyone. My name is Leonard [ph] and I will be your conference operator.

image for news BBB Foods Inc. (TBBB) Q1 2025 Earnings Call Transcript

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q1 2025 Earnings Conference Call May 8, 2025 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer & Principal Financial Officer Conference Call Participants Meghan Holtz - Jefferies Pito Chickering - Deutsche Bank Benjamin Rossi - JPMorgan Chase & Company Benjamin Hendrix - RBC Capital Markets Grayson McAlister - Truist Securities Operator Good morning and welcome to Aveanna Healthcare Holdings First Quarter 2025 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks …

image for news Aveanna Healthcare Holdings Inc. (AVAH) Q1 2025 Earnings Call Transcript

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript — Neutral

SOLV   Seeking Alpha — May 11, 2025

Solventum Corporation (NYSE:SOLV ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations & External Finance Communications Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley Frederick Wise - Stifel, Nicolaus & Company, Inc. Jason Bednar - Piper Sandler & Co. David Roman - Goldman Sachs Group, Inc. Travis Steed - Bank of America Steven Valiquette - Mizuho Securities Operator Good afternoon. My name is Amy [ph] and I will be your conference call operator for …

image for news Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript